Cargando…

Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays

INTRODUCTION: SARS-CoV-2 seroconversion is important for epidemiological studies as well as contact tracing. MATERIAL AND METHODS: The antibody response against SARS-CoV-2 was examined in 111 patients with a positive qRT-PCR. Seroconversion was assessed using the Elecsys from Roche, the Liaison S1/S...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolff, Fleur, Dahma, Hafid, Duterme, Cécile, Van den Wijngaert, Sigi, Vandenberg, Olivier, Cotton, Frédéric, Montesinos, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354376/
https://www.ncbi.nlm.nih.gov/pubmed/32829098
http://dx.doi.org/10.1016/j.diagmicrobio.2020.115140
_version_ 1783558072204001280
author Wolff, Fleur
Dahma, Hafid
Duterme, Cécile
Van den Wijngaert, Sigi
Vandenberg, Olivier
Cotton, Frédéric
Montesinos, Isabel
author_facet Wolff, Fleur
Dahma, Hafid
Duterme, Cécile
Van den Wijngaert, Sigi
Vandenberg, Olivier
Cotton, Frédéric
Montesinos, Isabel
author_sort Wolff, Fleur
collection PubMed
description INTRODUCTION: SARS-CoV-2 seroconversion is important for epidemiological studies as well as contact tracing. MATERIAL AND METHODS: The antibody response against SARS-CoV-2 was examined in 111 patients with a positive qRT-PCR. Seroconversion was assessed using the Elecsys from Roche, the Liaison S1/S2 IgG from Diasorin, the IgG and IgA from Euroimmun, as well as the VIDAS IgG and IgM. Specificity was estimated based on the measurement of SARS-CoV-2 antibodies in 96 residual samples collected during a non-pandemic period. RESULTS: The highest overall sensitivity for detecting seroconversion was obtained using the Elecsys (81.1%), the Euroimmun with a combined detection of IgG/IgA (86.5%), and the VIDAS with a simultaneous measurement of IgG/IgM (78.4%).The Elecsys and the VIDAS IgG/IgM demonstrated a specificity as well as a positive predictive value of 100%. CONCLUSIONS: The Elecsys and the VIDAS methods with a combination of IgG/IgM measurement demonstrated a high sensitivity with no false positive results.
format Online
Article
Text
id pubmed-7354376
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-73543762020-07-13 Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays Wolff, Fleur Dahma, Hafid Duterme, Cécile Van den Wijngaert, Sigi Vandenberg, Olivier Cotton, Frédéric Montesinos, Isabel Diagn Microbiol Infect Dis Virology INTRODUCTION: SARS-CoV-2 seroconversion is important for epidemiological studies as well as contact tracing. MATERIAL AND METHODS: The antibody response against SARS-CoV-2 was examined in 111 patients with a positive qRT-PCR. Seroconversion was assessed using the Elecsys from Roche, the Liaison S1/S2 IgG from Diasorin, the IgG and IgA from Euroimmun, as well as the VIDAS IgG and IgM. Specificity was estimated based on the measurement of SARS-CoV-2 antibodies in 96 residual samples collected during a non-pandemic period. RESULTS: The highest overall sensitivity for detecting seroconversion was obtained using the Elecsys (81.1%), the Euroimmun with a combined detection of IgG/IgA (86.5%), and the VIDAS with a simultaneous measurement of IgG/IgM (78.4%).The Elecsys and the VIDAS IgG/IgM demonstrated a specificity as well as a positive predictive value of 100%. CONCLUSIONS: The Elecsys and the VIDAS methods with a combination of IgG/IgM measurement demonstrated a high sensitivity with no false positive results. Elsevier Inc. 2020-11 2020-07-12 /pmc/articles/PMC7354376/ /pubmed/32829098 http://dx.doi.org/10.1016/j.diagmicrobio.2020.115140 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Virology
Wolff, Fleur
Dahma, Hafid
Duterme, Cécile
Van den Wijngaert, Sigi
Vandenberg, Olivier
Cotton, Frédéric
Montesinos, Isabel
Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays
title Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays
title_full Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays
title_fullStr Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays
title_full_unstemmed Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays
title_short Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays
title_sort monitoring antibody response following sars-cov-2 infection: diagnostic efficiency of 4 automated immunoassays
topic Virology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354376/
https://www.ncbi.nlm.nih.gov/pubmed/32829098
http://dx.doi.org/10.1016/j.diagmicrobio.2020.115140
work_keys_str_mv AT wolfffleur monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays
AT dahmahafid monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays
AT dutermececile monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays
AT vandenwijngaertsigi monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays
AT vandenbergolivier monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays
AT cottonfrederic monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays
AT montesinosisabel monitoringantibodyresponsefollowingsarscov2infectiondiagnosticefficiencyof4automatedimmunoassays